Bacterial DNA replication process

Bacterial DNA replication process" is not itself a single molecular target, but rather a complex, multi-enzyme process fundamental to bacterial cell proliferation. In bacteria such as *Escherichia coli*, the process involves coordinated action of multiple protein complexes and enzymes, including the origin recognition protein DnaA, the replicative DNA helicase DnaB (with loaders DnaC and, in some Gram-positives, DnaI/DnaD), DNA primase DnaG (for RNA primer synthesis), and the main polymerase, DNA polymerase III (with core subunits α/PolIIIα in the C-family of DNA polymerases), among others[1][5][2][4]. Accessory proteins include single-stranded DNA binding protein (SSB), processivity clamps, and the clamp loader complex[2][5]. Topoisomerases such as DNA gyrase and topoisomerase IV relieve topological stress caused by unwinding and are primary antibacterial drug targets[3][6]. The process comprises sequential steps: initiation (origin recognition, helicase loading, primer synthesis), elongation (DNA synthesis with leading and lagging strand coordination, Okazaki fragment maturation), and termination (resolving chromosome catenanes, disassembly of complexes)[1][3][4]. Because "bacterial DNA replication process" describes an essential pathway involving numerous components, it is not an individual molecular target, receptor, protein, or gene product, but rather an umbrella term referring to a cellular process targeted at multiple levels by different antibiotics and under active research for novel antimicrobial strategies[1][3][6]. Key point: The input term "Bacterial DNA replication process" is **not a canonical name for a molecular target**, but a multi-component process comprising several validated antibacterial targets, primarily enzymes such as DNA gyrase and topoisomerase IV[3]. - For structured data extraction, each enzyme involved (e.g., DNA gyrase, DNA polymerase III) would be an individual target, not the overall process itself.

Other names

DNA replication in bacteriabacterial DNA synthesisprokaryotic DNA replication

- Inhibition of DNA gyrase (type II topoisomerase)—prevents DNA supercoiling, halting replication (quinolones, fluoroquinolones)[3] - Inhibition of topoisomerase IV—prevents decatenation/separation of newly replicated chromosomes (quinolones, novobiocin)[3] - Interruption of replication initiation—targeting DnaA or primase (no clinical drugs currently, but under investigation)[1][7]